SARS-CoV-2疫苗接种后间质性肺疾病急性加重:病例系列
本文报告3例间质性肺疾病(ILD)患者在接种SARS-CoV-2 mRNA疫苗后出现急性呼吸衰竭,均为男性,平均年龄77岁,吸烟史10–30包年。呼吸衰竭出现时间为接种后1天(2例)和9天(1例)。1例尸检显示在寻常型间质性肺炎背景上叠加弥漫性肺泡损伤;另2例CT显示弥漫性磨玻璃影和胸膜下网格影,提示ILD急性加重。2例经大剂量甲泼尼龙治疗成功。作者认为疫苗接种获益大于不常见不良事件的风险,但慢性肺病患者接种后应仔细观察。
要点
- 3例ILD患者(均男性,平均年龄77岁,吸烟10–30包年)在SARS-CoV-2 mRNA疫苗接种后1天(2例)或9天(1例)出现急性呼吸衰竭
- 1例尸检病理示寻常型间质性肺炎背景上叠加弥漫性肺泡损伤
- 另2例CT示弥漫性磨玻璃影和胸膜下网格影,提示ILD急性加重
- 2例经大剂量甲泼尼龙治疗成功
- 作者认为慢性肺病患者接种SARS-CoV-2疫苗后应仔细观察
适用人群与场景
- 间质性肺疾病患者,3例均为男性,平均年龄77岁,吸烟史10–30包年
- 场景为SARS-CoV-2 mRNA疫苗接种后出现急性呼吸衰竭
处置流程与药物剂量
- 2例使用大剂量甲泼尼龙治疗并成功(原文未写明具体剂量、途径与疗程)
红旗征与不能漏的情况
- ILD患者SARS-CoV-2疫苗接种后出现急性呼吸衰竭,需考虑ILD急性加重
- CT示弥漫性磨玻璃影和胸膜下网格影提示ILD急性加重
研究设计与关键结果
- 病例系列:3例ILD患者接种SARS-CoV-2 mRNA疫苗后发生急性呼吸衰竭,均男性,平均年龄77岁,吸烟史10–30包年
- 疫苗接种至呼吸衰竭发生时间:2例为1天,1例为9天
- 1例尸检病理示寻常型间质性肺炎背景上叠加弥漫性肺泡损伤
- 另2例CT示弥漫性磨玻璃影和胸膜下网格影,提示ILD急性加重
- 2例经大剂量甲泼尼龙治疗成功
证据类型、等级与局限
- 证据类型:病例系列
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为疫苗接种的获益大于不常见不良事件的风险
- 作者认为慢性肺病患者在SARS-CoV-2疫苗接种后应仔细观察
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
An acute exacerbation of interstitial lung disease (ILD) is an acute deterioration that can occur at any time and is associated with significant morbidity and mortality rates. We herein report three patients with ILD who experienced acute respiratory failure after SARS-CoV-2 messenger RNA vaccination. All the patients were male; the mean age was 77 years. They had a smoking history that ranged from 10 to 30 pack-years. Duration from the vaccination to the onset of respiratory failure was 1 day in two patients and 9 days in one patient. In an autopsied case, lung pathologic evidence indicated diffuse alveolar damage superimposed on usual interstitial pneumonia. In the other two cases, CT scans showed diffuse ground-glass opacities and subpleural reticulation, which suggests acute exacerbation of ILD. Two patients were treated successfully with high-dose methylprednisolone. Although benefits of vaccination outweigh the risks associated with uncommon adverse events, patients with chronic lung diseases should be observed carefully after SARS-CoV-2 vaccination.
参考来源
- Ishioka Y, Makiguchi T, Itoga M, et al. Acute Exacerbation of Interstitial Lung Disease After SARS-CoV-2 Vaccination: A Case Series. Chest. 2022. PMID: 36494131. doi:10.1016/j.chest.2022.08.2213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。